list : Biochemistry

  • Drug Discovery Symposium runs April 19-20

    The annual conference will feature an interdisciplinary cast of researchers, industry leaders and policymakers who will discuss advances in therapeutics, including COVID-19 treatments.

  • Biochemist Robert Baldwin dies at 93

    Baldwin propelled leaps in scientists’ understanding of how proteins assemble themselves into the three-dimensional shapes that are essential to their function.

  • High-risk, high-reward grants for researchers

    Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.

  • Biochemist Dale Kaiser dies

    Using a virus as an experimental system, Kaiser made fundamental discoveries that were instrumental in ushering in the era of recombinant DNA technology, often known as gene splicing.

  • Scrambled eggs self-organize

    The cytoplasm of ruptured frog eggs can self-organize into cell-like compartments that retain the ability to undergo divisions.

  • New incubator for life science innovation

    A recently vacated building in Stanford Research Park will be the future home of a new life science incubator and lab suites. Located near campus, this incubator will serve as an anchor for a preeminent life science district.

  • Helping with NASA twins study

    Stanford scientists and their collaborators found markers of immune-related stress and other molecular changes in the body of NASA astronaut Scott Kelly.

  • Mechanism underlying ‘workaholic’ heart

    A study led by Stanford Medicine researchers shows why so many mutations associated with hypertrophic cardiomyopathy, a heart disorder, alter a key constituent of muscle cells in a way that makes it work overtime.

  • How liver regenerates itself

    A subset of liver cells with high levels of telomerase renews the organ during normal cell turnover and after injury, according to Stanford researchers. The cells may also give rise to liver cancer.

  • Assay tweak could help disease detection

    The technique is based on an existing method called a proximity ligation assay, which converts the biomarker into a DNA sequence.